European Commission has authorised treatment for uncontrolled asthma patients
News
UK bolsters Valneva COVID-19 vaccine deal
UK government has signed a deal for a further 40 million doses of vaccine
Bayer’s Xarelto approved in the UK
First oral factor Xa inhibitor approved for paediatric venous thromboembolism
Millions could benefit from genetic screening before prescribing, new research finds
Research led by the University of East Anglia in collaboration Boots UK and Leiden University
NHS has offered COVID-19 vaccine to all eligible care homes in England
Latest figures mark a ‘major milestone’ in vaccination drive
Kesimpta and Vazkepa among latest CHMP recommendations
Bumper meeting saw 13 new medicines recommended for approval
EU authorisation for AstraZeneca’s COVID-19 vaccine
Jab authorised for use in individuals aged 18 years and older
EMA begins review of GBT’s sickle cell treatment Oxbryta
GBT is aiming for the approval of Oxbryta to treat haemolytic anaemia in patients with sickle cell disease
Valneva completes recruitment for Phase I/II COVID-19 vaccine study
Speciality vaccine company has also started production of vaccine candidate
AZ/Daiichi Sankyo’s antibody drug conjugates prove promising in early trials
Datopotamab deruxtecan and Enhertu were evaluated in non-small cell lung cancer patients
Novavax COVID-19 vaccine found to be 89.3% effective in UK trial
Meanwhile, Phase IIb results from South Africa trial demonstrated 60% efficacy
Invasive candidiasis treatment rezafungin wins orphan drug status
IC is a severe and life-threatening form of Candida infection
UK will offer its genomic expertise worldwide to identify new COVID-19 variants
The New Variant Assessment Platform will be led by Public Health England
Researchers identify existing drug’s potential for triple negative breast cancer
Study suggests that palbociclib could be used to treat around a fifth of people with TNBC
Lilly’s antibodies bamlanivimab and etesevimab show promise against COVID-19
Neutralising antibodies significantly reduced COVID-19-related hospitalisations and deaths
